Cargando…
mTOR inhibition abrogates human mammary stem cells and early breast cancer progression markers
BACKGROUND: Mammary physiology is distinguished in containing adult stem/progenitor cells that are actively amending the breast tissue throughout the reproductive lifespan of women. Despite their importance in both mammary gland development, physiological maintenance, and reproduction, the exact rol...
Autores principales: | Bouamar, Hakim, Broome, Larry Esteban, Lathrop, Kate Ida, Jatoi, Ismail, Brenner, Andrew Jacob, Nazarullah, Alia, Gorena, Karla Moncada, Garcia, Michael, Chen, Yidong, Kaklamani, Virginia, Sun, Lu-Zhe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10614399/ https://www.ncbi.nlm.nih.gov/pubmed/37904250 http://dx.doi.org/10.1186/s13058-023-01727-z |
Ejemplares similares
-
Activation of mammalian target of rapamycin (mTOR) in triple negative feline mammary carcinomas
por: Maniscalco, Lorella, et al.
Publicado: (2013) -
Th-POK regulates mammary gland lactation through mTOR-SREBP pathway
por: Zhang, Rui, et al.
Publicado: (2018) -
The Msi1-mTOR pathway drives the pathogenesis of mammary and extramammary Paget’s disease
por: Song, Yongli, et al.
Publicado: (2020) -
The antidepressant imipramine inhibits breast cancer growth by targeting estrogen receptor signaling and DNA repair events
por: Timilsina, Santosh, et al.
Publicado: (2022) -
Akt activation disrupts mammary acinar architecture and enhances proliferation in an mTOR-dependent manner
por: Debnath, Jayanta, et al.
Publicado: (2003)